Topic
Immune Checkpoint Inhibitors
18 Podcasts • 8 Cases • 4 Courses on BackTable
Episode # 75 • 04 Aug 2026
Applying CheckMate 8HW: Practical Updates for MSI-High CRC
with Dr. Cathy Eng, Dr. Jun Gong
Is it time to rethink the definition of “cure” for stage IV colorectal cancer? In this episode of BackTable Tumor Board, medical oncologist Jun Gong interviews Dr. Cathy Eng about updates from the phase III CheckMate-8HW trial in centrally confirmed MSI-high/dMMR metastatic colorectal cancer, comparing nivolumab/ipilimumab, nivolumab, and chemotherapy. They discuss initial findings demonstrating improved progression-free survival and response rates with combination immunotherapy, as well as safety considerations and how comorbidities and frailty guide the choice between single-agent and combination regimens.
This podcast is supported by
More on Immune Checkpoint Inhibitors
Loading recent podcasts…
Tumor Board # 75
Aug 3, 2026
with Dr. Cathy Eng, Dr. Jun Gong
Is it time to rethink the definition of “cure” for stage IV colorectal cancer? In this episode of BackTable Tumor...
2,000+ listens
Vascular & IR # 647
May 20, 2026
with Dr. Juan Gimenez, Dr. Ari Cohen, Dr. Jonathan Mizrahi
In treating hepatocellular carcinoma (HCC), the hardest question often isn’t which treatment to use, it’s who should...
Vascular & IR # 622
Mar 4, 2026
with Dr. Jennifer McQuade, Dr. Rahul Sheth, Dr. Tyler Sandow
When standard-of-care checkpoint blockade fails in metastatic melanoma, how can oncologists and interventional...
1,300+ listens
Tumor Board # 44
Jan 19, 2026
with Dr. Jonathan Mizrahi, Dr. Jun Gong
The FLOT regimen is the standard-of-care for upper gastroesophageal malignancies, but what if there were other drug...
Vascular & IR # 659
Jun 29, 2026
with Dr. Beau Toskich, Dr. Lingling Du, Dr. Tyler Sandow
How do you safely combine locoregional and systemic therapies to treat hepatocellular carcinoma (HCC) when traditional...
1,300+ listens
Tumor Board # 51
Mar 16, 2026
with Dr. Jennifer McQuade, Dr. Rahul Sheth, Dr. Tyler Sandow
When standard-of-care checkpoint blockade fails in metastatic melanoma, how can oncologists and interventional...
Tumor Board # 46
Feb 2, 2026
with Dr. William Moore, Dr. Daniel Sterman, Dr. Ben Cooper
Pulsed electric field (PEF) therapy is an emerging cancer treatment that utilizes short electrical pulses to disrupt...
Urology # 268
Oct 23, 2025
with Dr. Tyler Stewart, Dr. Bogdana Schmidt
With the introduction of checkpoint inhibitors into non-muscle invasive bladder cancer (NMIBC) management, who’s on...
1,200+ listens
Tumor Board Case
Jun 23, 2025
with Dr. Nirmish Singla, Dr. Jeannie Hoffman-Censits and Dr. Bogdana Schmidt
Tumor Board Case
Jun 23, 2025
with Dr. Nirmish Singla, Dr. Jeannie Hoffman-Censits and Dr. Bogdana Schmidt
Urology Case
Jun 9, 2025
with Dr. Jeannie Hoffman-Censits, Dr. Bogdana Schmidt and Dr. Nirmish Singla
Urology Case
Jun 9, 2025
with Dr. Jeannie Hoffman-Censits, Dr. Bogdana Schmidt and Dr. Nirmish Singla
Tumor Board Case
Jun 23, 2025
with Dr. Nirmish Singla, Dr. Jeannie Hoffman-Censits and Dr. Bogdana Schmidt
Tumor Board Case
Jun 23, 2025
with Dr. Nirmish Singla, Dr. Jeannie Hoffman-Censits and Dr. Bogdana Schmidt
Urology Case
Jun 9, 2025
with Dr. Jeannie Hoffman-Censits, Dr. Bogdana Schmidt and Dr. Nirmish Singla
Urology Case
Jun 9, 2025
with Dr. Jeannie Hoffman-Censits, Dr. Bogdana Schmidt and Dr. Nirmish Singla
Urology Course
3 hours, 28 lessons
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.